HALEOS LABS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Haleos Labs Limited (formerly SMS Lifesciences India Limited) has informed the exchanges that its trading window will remain closed from April 1, 2026, until 48 hours after the declaration of financial results for the quarter and financial year ended March 31, 2026. The closure applies to designated persons, their immediate relatives, and specified connected persons of the company and its subsidiary. The date of the board meeting to consider and approve these financial results will be communicated separately. This is a routine compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015.
This is a standard regulatory disclosure and does not directly impact shareholders. However, it signals that the company is approaching its year-end financial results announcement, which investors should watch for. Insiders are restricted from trading during this period, which is normal practice before results.